TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,223,427 | -93.1% | 146,343 | -79.6% | 0.00% | -94.9% |
Q2 2023 | $17,809,386 | +233.3% | 716,964 | +101.8% | 0.04% | +200.0% |
Q1 2023 | $5,342,930 | +8517.6% | 355,248 | +3283.6% | 0.01% | – |
Q3 2022 | $62,000 | -98.9% | 10,499 | -98.2% | 0.00% | -100.0% |
Q1 2022 | $5,531,000 | +9.4% | 581,587 | +118.5% | 0.02% | 0.0% |
Q4 2021 | $5,057,000 | +1898.8% | 266,176 | +935.4% | 0.02% | +466.7% |
Q1 2020 | $253,000 | -55.9% | 25,707 | -74.9% | 0.00% | 0.0% |
Q3 2018 | $574,000 | -16.2% | 102,571 | +97.0% | 0.00% | 0.0% |
Q2 2018 | $685,000 | – | 52,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |